A serum metabolomic analysis of HCV-infected patients successfully treated with IFN-free DAA regimens

Ceccotti Giorgia; Meoni Gaia; Tenori Leonardo; Gragnani Laura; Fognani Elisa; Gianni Elena; Luchinat Claudio; Zignego Anna Linda

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >A serum metabolomic analysis of HCV-infected patients successfully treated with IFN-free DAA regimens

【24h】

A serum metabolomic analysis of HCV-infected patients successfully treated with IFN-free DAA regimens

机译：HCV感染患者的血清代谢组分分析成功用IFN的DAA方案治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2016年第s1期|共1页
作者
Ceccotti Giorgia; Meoni Gaia; Tenori Leonardo; Gragnani Laura; Fognani Elisa; Gianni Elena; Luchinat Claudio; Zignego Anna Linda;
展开▼
作者单位

Univ Florence Florence Italy;

Univ Florence Florence Italy;

Univ Florence Florence Italy;

Univ Florence Florence Italy;

Univ Florence Florence Italy;

Univ Florence Florence Italy;

Univ Florence Florence Italy;

Univ Florence Florence Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. A serum metabolomic analysis of HCV-infected patients successfully treated with IFN-free DAA regimens [J] . Ceccotti Giorgia, Meoni Gaia, Tenori Leonardo, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：HCV感染患者的血清代谢组分分析成功用IFN的DAA方案治疗
2. Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141) [J] . Deuffic-BurbanS., SchwarzingerM., ObachD., Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2014,第1期

机译：我们应该等待无IFN的方案治疗HCV基因型1治疗幼稚患者吗？成本效益分析（ANRS 95141）
3. Efficacy and Safety of Sofosbuvir/Velpatasvir plus Ribavirin for 12 or 24 Weeks in Genotype 1 or 2 HCV-Infected Japanese Patients with Prior Treatment Failure to DAA-Based Regimens [J] . Izumi Namiki, Takehara Tetsuo, Chayama Kazuaki, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：Sofosbuvir / Velpatasvir Plus利韦林的疗效和安全性12或24周的基因型1或2个HCV感染的日本患者对基于DAA的方案进行的现有治疗失败
4. EXPLORING SERUM TARGETED METABOLOMICS MASS SPECTROMETRY PROFILE ANALYSIS TO IMPLEMENT RISK CRITERIA FOR FIRST-DEGREE RELATIVES (FDR) OF GASTRIC CANCER (GC) PATIENTS [C] . Giuseppe Corona, Renato Cannizzaro, Gianmaria Miolo, International Mass Spectrometry Conference . 2018

机译：探索血清靶向代谢组的质谱分析分析，实施胃癌（GC）患者一级亲属（FDR）的风险标准
5. Results of a randomized, controlled trial to assess the toxicity and patient adherence with two short-course regimens for the prevention of tuberculosis, a two-month regimen of rifampin and pyrazinamide or a four-month regimen of rifampin only, in comparison with a control regimen of six-months-isoniazid. [D] . Geiter, Lawrence James. 1997

机译：与对照相比，采用两种短期疗程预防结核病，两个月利福平和吡嗪酰胺治疗或仅四个月利福平治疗，评估毒性和患者依从性的随机对照试验结果六个月异烟肼的治疗方案。
6. Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols [O] . Valeria Caputo, Roberta Antonia Diotti, Enzo Boeri, 2020

机译：DAA治疗患者低水平HCV变体的检测：三种不同NGS数据分析协议的比较
7. PIN125 Validation and Psychometric Evaluation of the German-Translated Hepatitis C Virus Patient Reported Outcomes (HCV-PRO) Health and Wellbeing Instrument in German HCV-Infected Patients Treated with Direct Acting Antivirals (DAAS) with or Without Ribavirin (RBV) [O] . Anderson R.T., Baran R.W., Xie W., 2013

机译：在接受或不接受利巴韦林（RBV）的直接作用抗病毒药物（DAAS）治疗的德国HCV感染患者中，对德国翻译的丙型肝炎病毒患者报告的结局（HCV-PRO）健康状况进行PIN125验证和心理测量

A serum metabolomic analysis of HCV-infected patients successfully treated with IFN-free DAA regimens

著录项

相似文献

相关主题

期刊订阅